Webb14 nov. 2013 · Jutta Deckert, Peter U. Park, Sharon Chicklas, Yong Yi, Min Li, Katharine C. Lai, Michele F. Mayo, Christina N. Carrigan, Hans K. Erickson, Jan Pinkas, Robert J. Lutz, … Webb3 sep. 2013 · CD37 has gathered renewed interest as a therapeutic target in non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL); however, CD37-directed …
Paper: IMGN529, a Novel Antibody-Drug Conjugate (ADC ... - Confex
WebbLewis Chicklas (Andrew), 72 - Agawam, MA Has Court or Arrest Records at MyLife.com™ Home People Search C MA Agawam Lewis Chicklas View Public Details & Court Records See Who's Searching for You See Sites with Your Personal Info Make Changes to What Other's See Lock Sections of Your Profile Request Personal Reviews & References Webb14 nov. 2013 · Immunofluorescence histology of a biopsy sample from a kidney undergoing T-cell–mediated rejection after transplantation. Depicted is the increase in IL-17 production by kidney epithelial cells (green) during the inflammatory rejection reaction and the infiltration of high numbers of tissue-destructive CD4 + IL-17-producing (red and … how to respond to ttyl
Potent B-Cell Depletion by IMGN529, a CD37-Targeting Antibody ...
Webb18 nov. 2011 · Jutta Deckert, Sharon Chicklas, Yong Yi, Min Li, Jan Pinkas, Thomas Chittenden, Robert J. Lutz, Peter U. Park; Potent B-Cell Depletion by IMGN529, a CD37 … Webb14 aug. 2013 · Sharon Chicklas Show all 14 authors Abstract Previously identified anti-CD20 antibodies have been classified as either Type I antibodies with lipid raft and complement-dependent cytotoxicity... WebbCD37 has gathered renewed interest as a therapeutic target in non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL); however, CD37-directed antibody-drug conjugates (ADCs) have not been explored. Here, we identified a novel anti-CD37 antibody, K7153A, with potent in vitro activity against B-cell lines through multiple mechanisms … how to respond to to hell with the thalmor